FDA’s New Enforcement Policy: A Win for Remote Patient Monitoring and Remote Therapeutic Monitoring Manufacturers
FDA Issues New Warning Regarding Compounded Ketamine
FDA Laboratory Developed Test Oversight: What Stakeholders Need to Know About Proposed Overhaul
DTC Promotional Labeling and Advertisements: Quantitative Efficacy Wins Over FDA in Final Guidance on Presenting Risk Information
Clinical Trials: Consent Process Clarified in New FDA Final Guidance
Decentralized Clinical Trials: Sponsor Responsibilities
Decentralized Clinical Trials: Investigator Responsibilities
Key Takeaways from the FDA’s First Draft Guidance on Clinical Trials with Psychedelic Drugs
Regulation of Digital Health Products by FDA
Subscribe: Subscribe via RSS